Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth.

Bussolino, F, Di Renzo, M F, Ziche, M, Bocchietto, E, Olivero, M, Naldini, L, Gaudino, G, Tamagnone, L +2 more·1992·The Journal of cell biology

Cited by (1,000)

Items 101–200 of 1,000

  1. Heterogeneity of proangiogenic features in mesenchymal stem cells derived from bone marrow, adipose tissue, umbilical cord, and placenta
    Du, Wen Jing, Chi, Ying, Yang, Zhou Xin, Li, Zong Jin, Cui, Jun Jie, Song, Bao Quan, Li, Xue, Yang, Shao Guang, Han, Zhi Bo, Han, Zhong Chao · 2016 · Stem Cell Research & Therapy
  2. The emerging role of MET/HGF inhibitors in oncology
    Giorgio V. Scagliotti, Silvia Novello, Joachim von Pawel · 2013 · Cancer Treatment Reviews
  3. Series Introduction: Invasive growth: from development to metastasis
    Paolo Maria Comoglio, Livio Trusolino · 2002 · Journal of Clinical Investigation
  4. Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas
    Martina Olivero, M Rizzo, Roberto Madeddu, Caterina Casadio, Selma Pennacchietti, MR Nicotra, María Prat, Giuliano Maggi, N Arena, PG Natali et al. · 1996 · British Journal of Cancer
  5. Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis
    Yu-Wen Zhang, Lingmei Wang, Richard Jove, George F. Vande Woude · 2002 · Oncogene
  6. Cardiac fibrosis: potential therapeutic targets
    Shuin Park, Ngoc B. Nguyen, Arash Pezhouman, Reza Ardehali · 2019 · Translational research
  7. Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGF
    María Prat, Tiziana Crepaldi, Selma Pennacchietti, Federico Bussolino, Paolo Maria Comoglio · 1998 · Journal of Cell Science
  8. Quantitative analysis of vascular endothelial growth factor in primary breast cancer
    Masakazu Toi, Shinichi Kondo, Hideo Suzuki, Yutaka Yamamoto, Kazuo Inada, Takashi Imazawa, Tadaaki Taniguchi, Takeshi Tominaga · 1996 · Cancer
  9. Circulating haemopoietic and endothelial progenitor cells are decreased in COPD
    Paolo Palange, Ugo Testa, Alice Huertas, Luana Calabrò, Roberto Antonucci, Eleonora Petrucci, Elvira Pelosi, Luca Pasquini, A. Satta, G. Morici et al. · 2006 · European Respiratory Journal
  10. Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action
    Renhai Cao, Meit A. Björndahl, Marta Ines Gallego, Shaohua Chen, Piotr Religa, Anker Jón Hansen, Yihai Cao · 2006 · Blood
  11. Toward the biomimetic implant surface: Biopolymers on titanium-based implants for bone regeneration
    Ricardo Tejero, Eduardo Anitua, Gorka Orive · 2014 · Progress in Polymer Science
  12. Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice
    Federica Maione, Stefania Capano, Donatella Regano, Lorena Zentilin, Mauro Giacca, Oriol Casanovas, Federico Bussolino, Guido Serini, Enrico Giraudo · 2012 · Journal of Clinical Investigation
  13. Galectin-3 Stimulates Cell Proliferation
    Hidenori Inohara, Shiro Akahani, Avraham Raz · 1998 · Experimental Cell Research
  14. Differences in angiogenic potential of classically vs alternatively activated macrophages
    Vitam Kodelja, C. Müller, Susanne Tenorio, Christa Schebesch, Constantin E. Orfanos, Sergij Goerdt · 1997 · Immunobiology
  15. Cross-talk between the proto-oncogenes Met and Ron
    Antonia Follenzi, Silvia Bakovic, Philippe Gual, Maria Cristina Stella, Paola Longati, Paolo Maria Comoglio · 2000 · Oncogene
  16. Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain.
    Waltraud Jung, Eero Ċastrén, Margarete Odenthal, George F. Vande Woude, T Ishii, Hans P. Dienes, D Lindholm, Peter Schirmacher · 1994 · The Journal of Cell Biology
  17. Met as a therapeutic target in HCC: Facts and hopes
    Silvia Giordano, Amedeo Columbano · 2013 · Journal of Hepatology
  18. Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma
    Orhan Sezer, Christian Jakob, Jan Eucker, Kathrin Niemöller, Frauke Gatz, Klaus‐Dieter Wernecke, Kurt Possinger · 2001 · European Journal Of Haematology
  19. Growth Factors in Inflammatory Bowel Disease
    Paul L. Beck, Daniel K. Podolsky · 1999 · Inflammatory Bowel Diseases
  20. Mechanosensing and Mechanoregulation of Endothelial Cell Functions
    Yun Hua Fang, David Wu, Konstantin G. Birukov · 2019 · Comprehensive physiology
  21. Stable interaction between α5β1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1
    Cascone, Ilaria, Napione, Lucia, Maniero, Fabrizio, Serini, Guido, Bussolino, Federico · 2005 · The Journal of Cell Biology
  22. Endothelial cells in the bone marrow of patients with multiple myeloma
    A. Vacca · 2003 · Blood
  23. Series Introduction: Invasive growth: from development to metastasis
    Paolo Maria Comoglio, Livio Trusolino · 2002 · Journal of Clinical Investigation
  24. Proliferation and invasion: Plasticity in tumor cells
    Chong-Feng Gao, Qian Reuben Xie, Yanli Su, Julie M. Koeman, Sok Kean Khoo, Margaret F. Gustafson, Beatrice S. Knudsen, Rick V. Hay, Nariyoshi Shinomiya, George F. Vande Woude · 2005 · Proceedings of the National Academy of Sciences
  25. Activation of Hepatocyte Growth Factor by two Homologous Proteases, Blood-Coagulation Factor XIIa and Hepatocyte Growth Factor Activator
    Takeshi Shimomura, Keiji Miyazawa, Yutaka Komiyama, Hirotoshi Hiraoka, Daiji Naka, Yuuki Morimoto, Naomi Kitamura · 1995 · European Journal of Biochemistry
  26. Common Lymphatic Endothelial and Vascular Endothelial Receptor-1 Mediates the Transmigration of Regulatory T Cells across Human Hepatic Sinusoidal Endothelium
    Shishir Shetty, Chris J. Weston, Ye Htun Oo, Nina Westerlund, Zania Stamataki, Janine Youster, Stefan G. Hübscher, Marko Salmi, Sirpa Jalkanen, Patricia F. Lalor et al. · 2011 · The Journal of Immunology
  27. HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro
    Shunli Ding, Tatyana Merkulova‐Rainon, Zhongchao Han, Gérard Tobelem · 2003 · Blood
  28. A Natural Hepatocyte Growth Factor/Scatter Factor Autocrine Loop in Myoblast Cells and the Effect of the ConstitutiveMetKinase Activation on Myogenic Differentiation
    Sergio Anastasi, Silvia Giordano, Olga Sthandier, Giovanna Gambarotta, Rossella Maione, Paolo Maria Comoglio, Paolo Amati · 1997 · The Journal of Cell Biology
  29. A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor.
    Elena Maestrini, Luca Tamagnone, Paola Longati, Ottavio Cremona, Massimo Gulisano, Silvia Bione, Filippo Tamanini, Benjamin G. Neel, Daniela Toniolo, Paolo Maria Comoglio · 1996 · Proceedings of the National Academy of Sciences
  30. HGF/SF: a potent cytokine for mammary growth, morphogenesis and development
    Birunthi Niranjan, Laki Buluwela, Jeffrey Yant, Nina P. Perusinghe, Amanda J. Atherton, Deborah Phippard, Trevor C. Dale, Barry A. Gusterson, Tahereh Kamalati · 1995 · Development
  31. Transgenic expression in the liver of truncated Met blocks apoptosis and permits immortalization of hepatocytes
    Laura Amicone, Francesca M. Spagnoli, Gerald Frank Späth, Silvia Giordano, Cristina Tommasini, Silvia Bernardini, Veronica De Luca, Carlo Della Rocca, Mary C. Weiss, Paolo Maria Comoglio et al. · 1997 · The EMBO Journal
  32. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
    Francesco Di Raimondo, Maria Pia Azzaro, Giuseppe A. Palumbo, Sabrina Bagnato, G Giustolisi, P. M. Floridia, Grazia Sortino, Rosario Giustolisi · 2000 · PubMed
  33. The motility signal of scatter factor/hepatocyte growth factor mediated through the receptor tyrosine kinase met requires intracellular action of Ras.
    Guido R. Hartmann, K. Michael Weidner, Heinz Schwarz, Walter Birchmeier · 1994 · Journal of Biological Chemistry
  34. How are proliferation and differentiation of melanocytes regulated?
    Tomohisa Hirobe · 2011 · Pigment Cell & Melanoma Research
  35. Hepatocyte growth factor enhances endothelial cell barrier function and cortical cytoskeletal rearrangement: potential role of glycogen synthase kinase‐3β
    Feng Liu, Kane L. Schaphorst, Alexander D. Verin, KERI JACOBS, Anna A. Birukova, Regina M. Day, Natalia V. Bogatcheva, Donald Paul Bottaro, Joe G. N. Garcia · 2002 · The FASEB Journal
  36. Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity
    Annalisa Petrelli, Paola Circosta, Luisa Granziero, Massimiliano Mazzone, Alberto Maria Pisacane, Silvia Fenoglio, Paolo Maria Comoglio, Silvia Giordano · 2006 · Proceedings of the National Academy of Sciences
  37. Cellular and molecular mechanisms of HGF/Met in the cardiovascular system
    Simona Gallo, Valentina Sala, Stefano Gatti, Tiziana Crepaldi · 2015 · Clinical Science
  38. Growth factors secreted by fibroblasts: role in healing diabetic foot ulcers
    Jonathan N Mansbridge, Kang Liu, R. Emmett Pinney, Ruth Patch, Anthony Ratcliffe, Gail K. Naughton · 1999 · Diabetes Obesity and Metabolism
  39. Angiogenesis in multiple myeloma
    Christian Jakob, Jan Sterz, Ivana Zavrski, Ulrike Heider, Lorenz Kleeberg, Claudia Fleissner, Martin Kaiser, Orhan Sezer · 2006 · European Journal of Cancer
  40. Structural and functional characterization of the mouse hepatocyte growth factor gene promoter.
    Youhua Liu, George K. Michalopoulos, Reza Zarnegar · 1994 · Journal of Biological Chemistry
  41. Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF.
    Carla Boccaccio, Giovanni Gaudino, Giovanna Gambarotta, Francesco Galimi, Paolo Maria Comoglio · 1994 · Journal of Biological Chemistry
  42. Phosphorylation of serine 985 negatively regulates the hepatocyte growth factor receptor kinase.
    Lucia Gandino, Paola Longati, Enzo Médico, María Prat, Paolo Maria Comoglio · 1994 · Journal of Biological Chemistry
  43. Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells
    Mary E. Gerritsen, James E Tomlinson, Constance H. Zlot, Michael Ziman, Stuart Hwang · 2003 · British Journal of Pharmacology
  44. Untitled work
    1999 · PubMed
  45. Growth Factor-Induced Tyrosine Phosphorylation of Hrs, a Novel 115-Kilodalton Protein with a Structurally Conserved Putative Zinc Finger Domain
    Masayuki Komada, Naomi Kitamura · 1995 · Molecular and Cellular Biology
  46. Mitogenic and Antiapoptotic Actions of Hepatocyte Growth Factor Through ERK, STAT3, and Akt in Endothelial Cells
    Hironori Nakagami, Ryuichi Morishita, Kei Yamamoto, Yoshiaki Taniyama, Motokuni Aoki, Kunio Matsumoto, Toshikazu Nakamura, Yasufumi Kaneda, Masatsugu Horiuchi, Toshio Ogihara · 2001 · Hypertension
  47. Spatiotemporal expression of angiogenesis growth factor receptors during the revascularization of regenerating rat liver
    Mark A. Ross, Christina M. Sander, Talia B. Kleeb, Simon C. Watkins, Donna Beer Stolz · 2001 · Hepatology
  48. Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene.
    Silvia Giordano, Z Zhen, Enzo Médico, Giovanni Gaudino, Francesco Galimi, Paolo Maria Comoglio · 1993 · Proceedings of the National Academy of Sciences
  49. Hepatocyte Growth Factor/Scatter Factor Binds with High Affinity to Dermatan Sulfate
    Malcolm Lyon, Jon A. Deakin, Hassan Rahmoune, David Garth Fernig, Toshikazu Nakamura, John T. Gallagher · 1998 · Journal of Biological Chemistry
  50. Plexin‐B3 is a functional receptor for semaphorin 5A
    Stefania Artigiani, Paolo Conrotto, Pietro Fazzari, Giorgio F. Gilestro, Davide Barberis, Silvia Giordano, Paolo Maria Comoglio, Luca Tamagnone · 2004 · EMBO Reports
  51. NK4 (HGF‐antagonist/angiogenesis inhibitor) in cancer biology and therapeutics
    Kunio Matsumoto, Toshikazu Nakamura · 2003 · Cancer Science
  52. HOXB7: a key factor for tumor-associated angiogenic switch.
    Alessandra Carè, Federica Felicetti, Ettore Meccia, Lisabianca Bottero, Mariella Parenza, Antonella Stoppacciaro, C Peschle, Mario P. Colombo · 2001 · PubMed
  53. Angiogenesis and the Tumor Microenvironment: Vascular Endothelial Growth Factor and Beyond
    Kriti Mittal, John M.L. Ebos, Brian I. Rini · 2014 · Seminars in Oncology
  54. Hepatocyte Growth Factor Promotes Cancer Cell Migration and Angiogenic Factors Expression: A Prognostic Marker of Human Esophageal Squamous Cell Carcinomas
    Yi Ren, Brian B. Cao, Simon Ying-Kit Law, Yi Xie, Ping Yin Lee, Leo C. M. Cheung, Yongxong Chen, Xin Huang, Hiu Man Chan, Ping Zhao et al. · 2005 · Clinical Cancer Research
  55. Oncogenic Mutants of RON and MET Receptor Tyrosine Kinases Cause Activation of the β-Catenin Pathway
    Alla Danilkovitch‐Miagkova, Alexei Miagkov, Alison Skeel, Noboru Nakaigawa, Berton Zbar, Edward J. Leonard · 2001 · Molecular and Cellular Biology
  56. Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts.
    K. Jin Kim, Lihong Wang, Yi-Chi Su, G. Yancey Gillespie, Amandeep Salhotra, Bachchu Lal, John Laterra · 2006 · Clinical Cancer Research
  57. IL-12 Inhibition of Endothelial Cell Functions and Angiogenesis Depends on Lymphocyte-Endothelial Cell Cross-Talk
    Marina Strasly, Federica Cavallo, Massimo Geuna, Stefania Maria Filomena Mitola, Mario P. Colombo, Guido Forni, Federico Bussolino · 2001 · The Journal of Immunology
  58. Angiogenesis, adipokines and breast cancer
    Vona-Davis, Linda, Rose, David P. · 2009 · Cytokine & Growth Factor Reviews
  59. Hepatocyte growth factor regulates human trophoblast motility and invasion: a role for nitric oxide
    Judith E. Cartwright, Desmond P. Holden, Guy St. J. Whitley · 1999 · British Journal of Pharmacology
  60. Microfluidic Tumor–Vascular Model to Study Breast Cancer Cell Invasion and Intravasation
    Nagaraju, Supriya, Truong, Danh, Mouneimne, Ghassan, Nikkhah, Mehdi · 2018 · Advanced Healthcare Materials
  61. Paracrine induction of angiogenesis in vitro by Swiss 3T3 fibroblasts
    Roberto Montesano, Michael Sean Pepper, Lelio Orci · 1993 · Journal of Cell Science
  62. Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells
    Hidenori Takahashi, Muneo Numasaki, Michael T. Lotze, Hidetada Sasaki · 2004 · Immunology Letters
  63. Diverse and potent activities of HGF/SF in skin wound repair
    Damon Bevan, Ermanno Gherardi, Tai‐Ping Fan, Dylan R. Edwards, R. M. Warn · 2004 · The Journal of Pathology
  64. IKKβ acts as a tumor suppressor in cancer-associated fibroblasts during intestinal tumorigenesis
    Charles Kisali Pallangyo, Paul K. Ziegler, Florian R. Greten · 2015 · The Journal of Experimental Medicine
  65. Hydroxyapatite coated with hepatocyte growth factor (HGF) stimulates human osteoblasts in vitro
    Giovanni Zambonin, C. Camerino, G. Greco, V. Patella, Biagio Moretti, Maria Grano · 2000 · Journal of Bone and Joint Surgery - British Volume
  66. A High Affinity Hepatocyte Growth Factor-binding Site in the Immunoglobulin-like Region of Met
    Cristina Basilico, Addolorata Arnesano, Maria Galluzzo, Paolo Maria Comoglio, Paolo Michieli · 2008 · Journal of Biological Chemistry
  67. The tumour–stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients
    Daiki Masuya, Cheng‐long Huang, D Liu, T Nakashima, Kotaro Kameyama, Reiji Haba, Masaki Ueno, Hiroyasu Yokomise · 2004 · British Journal of Cancer
  68. Higher Pericyte Content and Secretory Activity of Microfragmented Human Adipose Tissue Compared to Enzymatically Derived Stromal Vascular Fraction
    Bianca Vezzani, Isaac Shaw, Hanna Lesme, Li Yong, Nusrat Khan, Carlo Tremolada, Bruno Péault · 2018 · Stem Cells Translational Medicine
  69. Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists
    Paolo Michieli, Cristina Basilico, Selma Pennacchietti, Antonella Maffé, Luca Tamagnone, Silvia Giordano, Alberto Bardelli, Paolo Maria Comoglio · 1999 · Oncogene
  70. Inhibition of endothelial cell functions and of angiogenesis by the metastasis inhibitor NAMI-A
    Angelo Vacca, M. Bruno, Angelina Boccarelli, Mauro Coluccia, Doménico Ribatti, Alberta Bergamo, Spiridione Garbisa, L. Sartor, Gianni Sava · 2002 · British Journal of Cancer
  71. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Christine Dosquet, Marie‐Claude Coudert, Éric Lepage, J. Cabané, François Richard · 1997 · PubMed
  72. c-Met as a Target for Personalized Therapy
    Ingrid Garajová, Elisa Giovannetti, Guido Biasco, Godefridus J. Peters · 2015 · Translational Oncogenomics
  73. Cell Biology of Wound Healing
    Christopher J. Schaffer, Lillian B. Nanney · 1996 · International review of cytology
  74. Enhancement of Migration by Protein Kinase Cα and Inhibition of Proliferation and Cell Cycle Progression by Protein Kinase Cδ in Capillary Endothelial Cells
    Elizabeth O. Harrington, Joachim Löffler, Peter Richard Nelson, Kenneth Craig Kent, Michael Simons, J. Anthony Ware · 1997 · Journal of Biological Chemistry
  75. The tyrosine kinase receptors Ron and Sea control "scattering" and morphogenesis of liver progenitor cells in vitro.
    Enzo Médico, Adriana Maria Mongiovì, Janice L. Huff, Mary Anne Jelinek, Antonia Follenzi, Giovanni Gaudino, J. Thomas Parsons, Paolo Maria Comoglio · 1996 · Molecular Biology of the Cell
  76. Targeting the c-MET signaling pathway for cancer therapy
    Xiangdong Liu, Wenqing Yao, Robert Charles Newton, Peggy Scherle · 2008 · Expert Opinion on Investigational Drugs
  77. Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cells
    Kota Ishizawa, Hiroshi Kubo, Mitsuhiro Yamada, Seiichi Kobayashi, Takashi A. SUZUKI, Shinya Mizuno, Toshikazu Nakamura, Hidetada Sasaki · 2004 · Biochemical and Biophysical Research Communications
  78. Enhanced c-Met activity promotes G-CSF–induced mobilization of hematopoietic progenitor cells via ROS signaling
    Melania Tesio, Karin Golan, Simona Corso, Silvia Giordano, Amir Schajnovitz, Yaron Vagima, Shoham Shivtiel, Alexander Kalinkovich, Luisa Caione, Loretta Gammaitoni et al. · 2010 · Blood
  79. Placental Mesenchymal Stromal Cells Rescue Ambulation in Ovine Myelomeningocele
    Aijun Wang, Erin G. Brown, Lee Lankford, Benjamin A. Keller, Christopher D. Pivetti, Nicole Sitkin Zelin, Michael S. Beattie, Jacqueline C. Bresnahan, Diana Lee Farmer · 2015 · Stem Cells Translational Medicine
  80. Role of Cytokines and Chemokines in Angiogenesis in a Tumor Context
    Mannon Geindreau, Mélanie Bruchard, Frédérique Végran · 2022 · Cancers
  81. Hepatocyte Growth Factor/Scatter Factor Can Induce Angiogenesis Independently of Vascular Endothelial Growth Factor
    Shiladitya Sengupta, Ermanno Gherardi, Lynda A. Sellers, Jeanette Marjorie Wood, Ram Sasisekharan, Tai‐Ping D. Fan · 2003 · Arteriosclerosis Thrombosis and Vascular Biology
  82. cMET and Phospho-cMET Protein Levels in Breast Cancers and Survival Outcomes
    Kanwal P. S. Raghav, Wenting Wang, Shuying Liu, Mariana Chávez‐MacGregor, Xiaolong Meng, Gabriel N. Hortobágyi, Gordon Brent Mills, Funda Meric‐Bernstam, George R. Blumenschein, Ana Maria Gonzalez-Angulo · 2012 · Clinical Cancer Research
  83. Silencing the MET oncogene leads to regression of experimental tumors and metastases
    Simona Corso, Cristina Migliore, Elena Ghiso, Gaetano De Rosa, Paolo Maria Comoglio, Silvia Giordano · 2007 · Oncogene
  84. Concomitant Expression of Hepatocyte Growth Factor/Scatter Factor and the Receptor c-MET in Human Myeloma Cell Lines
    Magne Børset, Egil Lien, Terje Espevik, Eirik Helseth, Anders Waage, Anders Sundan · 1996 · Journal of Biological Chemistry
  85. A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats
    Hideki Ueda · 2001 · Cardiovascular Research
  86. Tyrosine 1356 in the carboxyl-terminal tail of the HGF/SF receptor is essential for the transduction of signals for cell motility and morphogenesis.
    Hongbo Zhu, Monica A. Naujokas, Elizabeth D. Fixman, Krikor Torossian, Morag Park · 1994 · Journal of Biological Chemistry
  87. Expression of the hepatocyte growth factor/c-Met pathway is increased at the cancer front in breast carcinoma
    Edakuni, Genichiro, Sasatomi, Eizaburo, Satoh, Toshimi, Tokunaga, Osamu, Miyazaki, Kohji · 2001 · Pathology International
  88. Potential Role of Hepatocyte Growth Factor, a Novel Angiogenic Growth Factor, in Peripheral Arterial Disease : Downregulation of HGF in Response to Hypoxia in Vascular Cells
    Seiya Hayashi, Ryuichi Morishita, Shinichiro Nakamura, Kei Yamamoto, Akira Moriguchi, Tomokazu Nagano, Mutsuo Taiji, Hiroshi Noguchi, Kunio Matsumoto, T. Nakamura et al. · 1999 · Circulation
  89. Activation of NF-κB Is Essential for Hepatocyte Growth Factor-Mediated Proliferation and Tubulogenesis
    Müller, Markus, Morotti, Alessandro, Ponzetto, Carola · 2002 · Molecular and Cellular Biology
  90. MET: A Critical Player in Tumorigenesis and Therapeutic Target
    Graveel, C. R., Tolbert, D., Vande Woude, G. F. · 2013 · Cold Spring Harbor Perspectives in Biology
  91. c-Met–mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma
    Huang, Menggui, Liu, Tianrun, Ma, Peihong, Mitteer, R. Alan, Zhang, Zhenting, Kim, Hyun Jun, Yeo, Eujin, Zhang, Duo, Cai, Peiqiang, Li, Chunsheng et al. · 2016 · Journal of Clinical Investigation
  92. Pathophysiological Changes to the Peritoneal Membrane during PD-Related Peritonitis: The Role of Mesothelial Cells
    Susan Yung, Tak Mao Chan · 2012 · Mediators of Inflammation
  93. HGF attenuates thrombin‐induced endothelial permeability by Tiaml‐mediated activation of the Rac pathway and by Tiam1/Rac‐dependent inhibition of the Rho pathway
    Anna A. Birukova, Elena A. Alekseeva, Arsen S. Mikaelyan, Konstantin G. Birukov · 2007 · The FASEB Journal
  94. HGF and MET: From Brain Development to Neurological Disorders
    C. Desole, Simona Gallo, Annapia Vitacolonna, Francesca Montarolo, A. Bertolotto, D. Vivien, P. Comoglio, T. Crepaldi · 2021 · Frontiers in Cell and Developmental Biology
  95. Nitric oxide‐mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen‐activated protein kinase
    Lorraine C. Jadeski, Chandan Chakraborty, Peeyush K. Lala · 2003 · International Journal of Cancer
  96. Oncogenic Pathways, Molecularly Targeted Therapies, and Highlighted Clinical Trials in Non–Small-Cell Lung Cancer (NSCLC)
    Thanyanan Reungwetwattana, Saravut John Weroha, Julian R. Molina · 2011 · Clinical Lung Cancer
  97. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
    Hiroaki Kataoka, Ryoichi Hamasuna, Hiroshi Itoh, N Kitamura, Masashi Koono · 2000 · PubMed
  98. Hepatocyte Growth Factor Is a Regulator of Monocyte-Macrophage Function
    Francesco Galimi, Erika Cottone, Elisa Vigna, Nicolò Arena, Carla Boccaccio, Silvia Giordano, Luigi Naldini, Paolo Maria Comoglio · 2001 · The Journal of Immunology
  99. Interleukin-17 augments tumor necrosis factor-α-induced elaboration of proangiogenic factors from fibroblasts
    Muneo Numasaki, Michael T. Lotze, Hidetada Sasaki · 2004 · Immunology Letters
  100. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis
    Y WANG, N AHMAD, Maqsood A. Wani, M ASHRAF · 2004 · Journal of Molecular and Cellular Cardiology